The K-Map Study, Global Prevalence of KC

Status: Recruiting
Location: See all (12) locations...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

Keratoconus is a ocular disease classified under ectatic diseases which often results in bilateral and asymmetrical corneal distortion. It usually affects patients at young age and can cause severe visual loss. The overall goal of this study is to assess the prevalence of keratoconus (KC) in children and adolescents in various regions of the world based on modern tomographic imaging methods, and to verify whether the occurrence rates reported from literature should be corrected. Our hypothesis is that the prevalence of the disease is much higher than that traditionally reported. At each site, corneal tomography examinations (Pentacam) will be performed bilaterally in children and adolescents, who are not ill or with any ophthalmological symptom. The population to be studied will be composed of children and adolescents on medical visits for non-ophthalmologic reasons, aged between 6 and 20 years. Multiple cities, from different continents (North America, South America, Asia and Europe) will participate.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 6
Maximum Age: 23
Healthy Volunteers: t
View:

• Male or female, 6-23 years of age.

• Subjects seen for a non-ophthalmic appointment

• Provide signed and dated patient consent form (signed by parents / legal guardians).

• Willing to comply with all study procedures and be available for the duration of the study

Locations
United States
California
USC Roski Eye Institute
RECRUITING
Los Angeles
Other Locations
China
Eye Hospital of Wenzhou Medical College
RECRUITING
Wenzhou
Croatia
RECRUITING
Zagreb
Egypt
RECRUITING
Alexandria
Germany
RECRUITING
Homburg
Islamic Republic of Iran
RECRUITING
Isfahan
Jordan
RECRUITING
Amman
Mexico
RECRUITING
Monterrey
Peru
RECRUITING
Lima
Russian Federation
Ufa Eye Research Intitute
COMPLETED
Ufa
Saudi Arabia
King Saud University
COMPLETED
Riyadh
Uzbekistan
RECRUITING
Bukhara
Contact Information
Primary
Farhad Hafezi, MDPhD
fhafezi@elza-institute.com
+41 44 741 81 81
Time Frame
Start Date: 2015-12-28
Estimated Completion Date: 2030-02-01
Participants
Target number of participants: 20000
Related Therapeutic Areas
Sponsors
Collaborators: ELZA Institute
Leads: University Hospital, Geneva

This content was sourced from clinicaltrials.gov